Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Raptor Pharma Says FDA Extends PROCYSBI NDA Review By 3 Months
Raptor Pharma Says FDA Extends PROCYSBI NDA Review By 3 Months
Raptor Pharma Says FDA Extends PROCYSBI NDA Review By 3 Months
Submitted by
admin
on December 22, 2012 - 1:00pm
Source:
NASDAQ
News Tags:
procysbi
Raptor Pharmaceuticals
nephropathic cystinosis
Headline:
Raptor Pharma Says FDA Extends PROCYSBI NDA Review By 3 Months
Do Not Allow Advertisers to Use My Personal information
